PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DXSE.DE vs. PPH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


DXSE.DEPPH
YTD Return10.03%13.38%
1Y Return13.97%21.87%
3Y Return (Ann)5.05%8.06%
5Y Return (Ann)8.10%10.76%
10Y Return (Ann)7.58%5.55%
Sharpe Ratio1.111.82
Sortino Ratio1.592.54
Omega Ratio1.191.32
Calmar Ratio1.151.95
Martin Ratio4.177.07
Ulcer Index3.51%2.74%
Daily Std Dev13.22%10.67%
Max Drawdown-34.30%-46.49%
Current Drawdown-11.92%-8.13%

Correlation

-0.50.00.51.00.5

The correlation between DXSE.DE and PPH is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

DXSE.DE vs. PPH - Performance Comparison

In the year-to-date period, DXSE.DE achieves a 10.03% return, which is significantly lower than PPH's 13.38% return. Over the past 10 years, DXSE.DE has outperformed PPH with an annualized return of 7.58%, while PPH has yielded a comparatively lower 5.55% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%5.00%10.00%JuneJulyAugustSeptemberOctoberNovember
-2.65%
2.75%
DXSE.DE
PPH

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


DXSE.DE vs. PPH - Expense Ratio Comparison

DXSE.DE has a 0.17% expense ratio, which is lower than PPH's 0.36% expense ratio.


PPH
VanEck Vectors Pharmaceutical ETF
Expense ratio chart for PPH: current value at 0.36% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.36%
Expense ratio chart for DXSE.DE: current value at 0.17% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.17%

Risk-Adjusted Performance

DXSE.DE vs. PPH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE) and VanEck Vectors Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DXSE.DE
Sharpe ratio
The chart of Sharpe ratio for DXSE.DE, currently valued at 0.91, compared to the broader market-2.000.002.004.000.91
Sortino ratio
The chart of Sortino ratio for DXSE.DE, currently valued at 1.36, compared to the broader market-2.000.002.004.006.008.0010.0012.001.36
Omega ratio
The chart of Omega ratio for DXSE.DE, currently valued at 1.16, compared to the broader market1.001.502.002.503.001.16
Calmar ratio
The chart of Calmar ratio for DXSE.DE, currently valued at 0.84, compared to the broader market0.005.0010.0015.000.84
Martin ratio
The chart of Martin ratio for DXSE.DE, currently valued at 3.08, compared to the broader market0.0020.0040.0060.0080.00100.003.08
PPH
Sharpe ratio
The chart of Sharpe ratio for PPH, currently valued at 1.89, compared to the broader market-2.000.002.004.001.89
Sortino ratio
The chart of Sortino ratio for PPH, currently valued at 2.69, compared to the broader market-2.000.002.004.006.008.0010.0012.002.69
Omega ratio
The chart of Omega ratio for PPH, currently valued at 1.34, compared to the broader market1.001.502.002.503.001.34
Calmar ratio
The chart of Calmar ratio for PPH, currently valued at 1.98, compared to the broader market0.005.0010.0015.001.98
Martin ratio
The chart of Martin ratio for PPH, currently valued at 7.17, compared to the broader market0.0020.0040.0060.0080.00100.007.17

DXSE.DE vs. PPH - Sharpe Ratio Comparison

The current DXSE.DE Sharpe Ratio is 1.11, which is lower than the PPH Sharpe Ratio of 1.82. The chart below compares the historical Sharpe Ratios of DXSE.DE and PPH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.001.502.002.503.00JuneJulyAugustSeptemberOctoberNovember
0.91
1.89
DXSE.DE
PPH

Dividends

DXSE.DE vs. PPH - Dividend Comparison

DXSE.DE has not paid dividends to shareholders, while PPH's dividend yield for the trailing twelve months is around 1.76%.


TTM20232022202120202019201820172016201520142013
DXSE.DE
Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PPH
VanEck Vectors Pharmaceutical ETF
1.76%2.09%1.55%1.62%1.66%1.77%1.97%1.92%2.43%1.93%1.71%2.03%

Drawdowns

DXSE.DE vs. PPH - Drawdown Comparison

The maximum DXSE.DE drawdown since its inception was -34.30%, smaller than the maximum PPH drawdown of -46.49%. Use the drawdown chart below to compare losses from any high point for DXSE.DE and PPH. For additional features, visit the drawdowns tool.


-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-14.57%
-8.13%
DXSE.DE
PPH

Volatility

DXSE.DE vs. PPH - Volatility Comparison

Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE) has a higher volatility of 3.73% compared to VanEck Vectors Pharmaceutical ETF (PPH) at 3.32%. This indicates that DXSE.DE's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%2.50%3.00%3.50%4.00%4.50%5.00%JuneJulyAugustSeptemberOctoberNovember
3.73%
3.32%
DXSE.DE
PPH